Intraventricular Haemorrhage Neonatal Clinical Trial
Official title:
Prophylactic Acetaminophen for Prevention Intraventricular Hemorrhage in Premature Infants
The purpose of this study is to determine whether acetaminophen is effective in prevention or reducing the severity of IVH in premature infants.
It will be a double-blind randomized control trial, single center. The study will include
neonates with a gestational age of less than or equal 32 weeks and a birth weight of less
than or equal 1500 g, and will randomly assigned to two treatment groups (see below).
Infants will be randomized to equal-sized groups using block randomization with blocks of
four. Stratified randomization for gender and gestational age will be included in the
randomized blocks. Gestational age will be divided into two categories: 23 weeks +0 day to
27 weeks +6 days, and from 28 weeks +0 day to 32 weeks +6 days. Gender (2) × gestational age
(2) will give 6 strata, requiring 6 separate random number lists to achieve randomization.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03019367 -
Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2
|
N/A |